New drug takes on superbug pneumonia in hospitals
NCT ID NCT06087536
First seen Mar 12, 2026 · Last updated May 16, 2026 · Updated 11 times
Summary
This study tests a new drug called OMN6 for a serious lung infection (pneumonia) caught in the hospital or from a breathing machine. The infection is caused by a hard-to-treat bacteria. About 54 adults will get either OMN6 or a placebo, along with standard antibiotics, to see if OMN6 is safe and how the body processes it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HOSPITAL-ACQUIRED BACTERIAL PNEUMONIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Omnix Medical Research Site
RECRUITINGBe’er Ya‘aqov, Israel
-
Omnix Medical Research Site
RECRUITINGHolon, Israel
-
Omnix Medical Research Site
RECRUITINGPetah Tikva, Israel
-
Omnix Medical Research Site
RECRUITINGRamat Gan, Israel
-
Omnix Medical Research Site
RECRUITINGRishon LeZiyyon, Israel
Conditions
Explore the condition pages connected to this study.